Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities

Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities

The long history of Cannabis sativa had its development stimulated and oriented for medicine after the discovery and chemical characterization of its main active ingredient, the 9-tetrahydrocannabinol (9-THC). Consequently, a binding site for 9-THC was identified in rat brains and the first cannabin...

Full description

Bibliographic Details
Main Authors: Pedro Cunha, Ana M Romão, Filipa Mascarenhas-Melo, Helena M Teixeira, Flávio Reis
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
Atherosclerosis
cannabinoids
cardiovascular system
endocannabinoids
hypertension
shock
ischemia/reperfusion
therapeutics
Online Access:http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2011;volume=3;issue=3;spage=350;epage=360;aulast=Cunha

Internet

http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2011;volume=3;issue=3;spage=350;epage=360;aulast=Cunha

Similar Items